Metraipolis › archive › dc_b9b4e4ecfea6

Development of tri-cistronic CLDN18.2 CAR-T cells incorporating PD-1/CD28 switch and cyclophilin A for enhanced solid tumor immunotherapy — Europe PMC PMID:41736320

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41736320
DOI
10.71150/jm.2510017
License (as archived)
solo-consultazione
Archived
2026-11-06T09:37:26.333Z
SHA-256 of the archived text
b4acc9c3c539f95a03014d0c872eaa8ef8a7433f0b1ecdfc27a897fa6ee99dc3
Stable URL of this page
https://metraipolis.com/documento/dc_b9b4e4ecfea6

How to cite

Development of tri-cistronic CLDN18.2 CAR-T cells incorporating PD-1/CD28 switch and cyclophilin A for enhanced solid tumor immunotherapy — Europe PMC PMID:41736320 — Europe PMC (en), https://europepmc.org/article/MED/41736320 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b9b4e4ecfea6 (Metraipolis archive dc_b9b4e4ecfea6, sha256 b4acc9c3c539f95a03014d0c872eaa8ef8a7433f0b1ecdfc27a897fa6ee99dc3)
BibTeX
@misc{dcb9b4e4ecfea6,
  title = {Development of tri-cistronic CLDN18.2 CAR-T cells incorporating PD-1/CD28 switch and cyclophilin A for enhanced solid tumor immunotherapy — Europe PMC PMID:41736320},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41736320},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b9b4e4ecfea6; sha256 b4acc9c3c539f95a03014d0c872eaa8ef8a7433f0b1ecdfc27a897fa6ee99dc3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41736320. Agents can read the archived copy with the MCP tool read_document.